Who is the CEO of Pharmaresearch Bio?

According to the DART company overview, Pharmaresearch Bio's representative director is 백승걸, 원치엽 (각자대표) (name as registered in Korean). The company was founded on 2009-10-28.

Where is Pharmaresearch Bio listed?

Pharmaresearch Bio trades on the Korea Exchange KONEX market under the ticker 217950. Its fiscal year ends in December.

Does Pharmaresearch Bio pay a dividend?

Pharmaresearch Bio did not pay a cash dividend for fiscal 2025, according to its annual report.

Does Pharmaresearch Bio have any recent filing signals?

Signals detected automatically from DART filings and quarterly results: Insider selling (officers or major shareholders reported cutting shares (30 days)). These are factual flags, not investment advice.

Which companies are in the same industry as Pharmaresearch Bio?

Under the Korean Standard Industrial Classification recorded on DART, Pharmaresearch Bio is grouped with 107 other listed companies in pharmaceuticals. The most covered in Korean news over the past 30 days are Hanmi Pharm, Yuhan and Daewoong Pharma.

Pharmaresearch Bio KRX:217950KONEX

파마리서치바이오 · Korean news coverage and regulatory filings, organized.

한국어

Articles, 24h0

Articles, 7 days1

DART filings, 7 days2

Articles tracked3since Sep 11

Pharmaresearch Bio (파마리서치바이오) appeared in 1 Korean news article and 2 DART filings over the past seven days. Coverage peaked on Oct 20 with 1 article. The most common catalyst was stakes & m&a (1).

Filing signals Insider selling Screener

Pharmaresearch Bio top stories 2 weeks, by number of outlets

1
파마리서치바이오, 290억 CB 주식전환…모회사 지분 확대 여부 주목 [fn마켓워치]
1 outlets · 1 articlesFirst report Oct 26 14:26 파이낸셜뉴스Stake / acquisition
2
파마리서치바이오, 2공장 지연에도 유동성 436억 유지…본업이 버팀목
1 outlets · 1 articlesFirst report Oct 20 15:22 블로터
3
파마리서치바이오, 제4회차 CB 290억원 전환청구권 행사
1 outlets · 1 articlesFirst report Oct 22 17:41 디지털투데이

Latest Pharmaresearch Bio news Korean headlines

Oct 2614:26

파마리서치바이오, 290억 CB 주식전환…모회사 지분 확대 여부 주목 [fn마켓워치]
파이낸셜뉴스Stake / acquisition
Oct 2217:41

파마리서치바이오, 제4회차 CB 290억원 전환청구권 행사
디지털투데이
Oct 2015:22

파마리서치바이오, 2공장 지연에도 유동성 436억 유지…본업이 버팀목
블로터

Articles per day 2 weeks

120

122

126

Company profile

CEO: 백승걸, 원치엽 (각자대표)
Industry: Pharmaceuticals
Founded: 2009-10-28
Fiscal year-end: December
Head office: 강원도 강릉시
Website: pr-bio.co.kr
Quotes & chart: Naver Securities (Korean)

From the DART company overview.

Major shareholders latest 5%+ report per holder

Korea 5% stake disclosures

파마리서치62.02%
신한캐피탈5.60%

Each holder's most recent 5% ownership report on DART; names as filed in Korean.

Same industry Pharmaceuticals

All in industry

Company	Latest quarter op. profit	Articles 30d
Hanmi Pharm	₩131bn	655
Yuhan	₩66.9bn	484
Daewoong Pharma	₩68.1bn	372
GC Biopharma	₩1.7bn	326
DongKookPharmaceutical	₩26.1bn	259
Daewon Pharmaceutical	−₩9m	197
Kwangdong Pharmaceutical	₩2.8bn	188
JW Pharmaceutical	₩33.3bn	185

Compare Pharmaresearch Bio side by side with these companies

Pharmaresearch Bio DART filings

Oct 2916:19

Insider ownership report 임원ㆍ주요주주특정증권등소유상황보고서
Ownership reports
Oct 2916:08

5% ownership report 주식등의대량보유상황보고서(일반)
Ownership reports
Oct 2217:08

Other 전환청구권행사 (제4회차)
Other
Oct 617:53

Investor relations event 기업설명회(IR)개최결과
Other
Sep 1717:58

Investor relations event 기업설명회(IR)개최
Other

Catalysts 2 weeks

Stakes & M&A1

Mentioned alongside 2 weeks

No co-mentioned companies yet.

Pharmaresearch Bio FAQ

Who is the CEO of Pharmaresearch Bio?: According to the DART company overview, Pharmaresearch Bio's representative director is 백승걸, 원치엽 (각자대표) (name as registered in Korean). The company was founded on 2009-10-28.
Where is Pharmaresearch Bio listed?: Pharmaresearch Bio trades on the Korea Exchange KONEX market under the ticker 217950. Its fiscal year ends in December.
Does Pharmaresearch Bio pay a dividend?: Pharmaresearch Bio did not pay a cash dividend for fiscal 2025, according to its annual report.
Does Pharmaresearch Bio have any recent filing signals?: Signals detected automatically from DART filings and quarterly results: Insider selling (officers or major shareholders reported cutting shares (30 days)). These are factual flags, not investment advice.
Which companies are in the same industry as Pharmaresearch Bio?: Under the Korean Standard Industrial Classification recorded on DART, Pharmaresearch Bio is grouped with 107 other listed companies in pharmaceuticals. The most covered in Korean news over the past 30 days are Hanmi Pharm, Yuhan and Daewoong Pharma.